IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Corporate Subsidiaries
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IOVA
CIK: 1425205
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerMichael Formolo
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-05 | 2026-10-05 | FORM 8-K | 0001104659-26-113763 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | OWNERSHIP DOCUMENT | 0001104659-26-113342 | View SEC Doc Filr Page |
| 3 | 2026-10-02 | 2026-09-30 | OWNERSHIP DOCUMENT | 0001104659-26-113341 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-29 | FORM 8-K | 0001104659-26-111583 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | OWNERSHIP DOCUMENT | 0001104659-26-106752 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | OWNERSHIP DOCUMENT | 0001104659-26-106750 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | OWNERSHIP DOCUMENT | 0001104659-26-106748 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | OWNERSHIP DOCUMENT | 0001104659-26-105101 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | OWNERSHIP DOCUMENT | 0001104659-26-105100 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | OWNERSHIP DOCUMENT | 0001104659-26-105099 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | OWNERSHIP DOCUMENT | 0001104659-26-095040 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | OWNERSHIP DOCUMENT | 0001104659-26-093482 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000486 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001104659-26-092145 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001104659-26-091716 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001104659-26-091619 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0002012383-26-002600 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-30 | FORM 8-K | 0001104659-26-080409 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075863 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075861 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075858 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075856 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075854 | View SEC Doc Filr Page |
| S-8 | 2026-06-18 | — | FORM S-8 | 0001104659-26-075832 | View SEC Doc Filr Page |
| S-8 | 2026-06-18 | — | FORM S-8 | 0001104659-26-075831 | View SEC Doc Filr Page |